AzTrials
AzTrials

StrokeNCT07155161

Backward Walking and Related Factors in Individuals With Stroke

An observational study of Stroke, run by Gaziantep Islam Science and Technology University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objective: To examine the relationship between backward walking ability and lower extremity function, proprioception, trunk control, and balance in individuals with stroke. Thirty individuals aged 30-85 who have had a stroke will be included in our study. Read more about this study

Who is it for?
Ages 30 to 85 years
Conditions the study is for
Stroke
What is being tested?
Assesment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Sep 2025to 25 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Stroke Patients

Who may be able to join

  • who can walk 10 meters without physical assistance,
  • Lower extremity functions are in stages 2-6 of the Brunnstrom motor recovery scale,
  • Have been at least 3 days and no more than 24 months post-stroke,
  • Scored 24 or higher on the Mini Mental Test

Who cannot join

  • Individuals with neurological or orthopedic problems other than stroke that affect walking,
  • A history of cardiovascular or rheumatological diseases that interfere with daily activities,
  • A lower extremity lesion or fracture,
  • Lower extremity spasticity of 4 on the Modified Ashworth Scale (MAS),
  • Aphasia or communication disorders

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gaziantep Islam Science and Technology University

    Gaziantep

Other trials in Turkey (Türkiye)

About this study

Official title: Relationship Backwalking Ability and Lower Extremity Function, Proprioception, Trunk Control, And Balance Iduals With Stroke

Objective: To examine the relationship between backward walking ability and lower extremity function, proprioception, trunk control, and balance in individuals with stroke. Thirty individuals aged 30-85 who have had a stroke will be included in our study. Individuals with stroke who can walk 10 m without physical assistance, whose lower extremity functions are in the Brunnstrom motor recovery stages 2-6, who have been post-stroke for at least 3 days and up to 24 months, and who score 24 or higher on the Mini Mental Test will be included. Demographic information of individuals with stroke who meet the inclusion criteria will be recorded in a personal information form. Lower extremity function will be evaluated with the 3-meter back walking test (3MGYT), proprioception with the Fugl Meyer lower extremity assessment scale, with a digital goniometer, trunk control with the Trunk Impairment scale, and balance with the Brief BESTTest.

Read the detailed description

Stroke survivors often experience lower walking performance and muscle strength than healthy individuals. Despite advances in acute stroke treatment, patients continue to require rehabilitation due to spasticity, upper and lower extremity dysfunction, shoulder and back pain, dysphagia, and deficits in mobility and gait, vision, perception, and communication. Approximately 40% of patients experience functional impairment after stroke onset, and 15-30% experience severe motor, sensory, and cognitive impairments. While some patients lose ambulation completely after stroke, in others, impaired balance reactions and increased postural sway contribute to fear of falling and an increased risk of falling. Walking backwards is necessary to perform activities of daily living, such as leaning back in a chair and opening a door. This movement can be particularly challenging for the elderly and individuals with neurological deficits. Mechanical measurements of backward walking, particularly speed, stride length, and double support base, have been noted to significantly decrease in older adults. It suggests that the inability to take effective backward steps may predispose older adults to a decrease in functional walking ability and an increased risk of falls. Therefore, we believe that identifying the factors that influence backward walking ability in stroke survivors will contribute to rehabilitation programs that include walking training. This study is the first to examine the factors that influence backward walking ability in stroke patients in relation to proprioception, trunk control, lower extremity function, and balance.

Conditions
Stroke
Being tested
Assesment
Keywords
stroke, back ward walking, proprioception, trunk control, balance
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AssesmentOther

    assessment

Study groups in NCT07155161
Study groupRoleWhat they receive
StrokeStroke Patients
Receives: Other: Assesment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 3 meter backward walking

    In the 3MBT, a three-meter distance will be measured on a flat surface and the start and end will be marked. The patient will be asked to walk backward when prompted to start, and will be asked to stop when prompted to stop. Individuals will be allowed to look back if they wish. For safety reasons, the tester will be allowed to walk with the patients. Measurements will be repeated three times and averaged.

    Measured: At baseline

  2. Fugl-Meyer Lower Extremity Scale

    The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based measure. Measurements are taken with the patient seated on a flat bed, such as a stretcher. Each parameter is scored as 0: Failure, 1: Partially Successful, and 2: Completely Successful. Motor function and sensory sections of the scale are used. The motor function assessment section is scored as 100 points, with 66 for the upper extremities and 34 for the lower extremities, and the sensory assessment section, which includes light touch and position sense, is scored as 24 points. A higher score indicates a better condition. It is a widely used, reliable, and valid test for assessing paretic upper and lower extremity motor impairments in stroke patients.

    Measured: At baseline

  3. Proprioception

    The patients' range of motion of the hip, knee, and ankle joints on the affected side is measured by fixing a digital goniometer to the joint. Data will be recorded in degrees. Patients will then be asked to half-jointly move their hip, knee, and ankle joints, without being able to see them. The difference between half of the normal joint movement and half of the joint movement performed with eyes closed will be noted. Assessments will be performed in both the prone and supine positions.

    Measured: At baseline

  4. Trunk Impairment Scale

    The Trunk Impairment Scale is a 17-item scale with three subsections that assess static sitting balance, dynamic sitting balance, and coordination. The starting position for the scale is with the individual in a 90º flexed knee, soles of the feet touching the floor, hands on the thighs, and no back support. Measurements will be repeated three times, and the individual's best results will be recorded. The lowest possible score is 0, and the highest is 23. A high score indicates good trunk control.

    Measured: At baseline

  5. Brief-Bestest

    It's a low-cost test that can be completed quickly with minimal equipment. It consists of six balance parameters. Measurements are made with a stopwatch on a flat surface. These include biomechanical constraints, stability limitations, transitions-preparatory postural alignment, reactive postural response, sensory orientation, and gait balance. Each question can be scored from a minimum of 0 to a maximum of 3, and the test can achieve a maximum of 24 points.

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2025
  2. Study start15 Sep 2025
  3. Primary completion15 Feb 2026
  4. Study completion25 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07155161
Sponsor's protocol ID
ipekkirmaci..
Status last verified
Oct 2026
First submitted
27 Aug 2025
Last updated
21 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Gaziantep Islam Science and Technology University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

3 meter backward walking (time frame: At baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in